During the past decade, Sidney Kimmel Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sidney Kimmel Cancer Center" #1 sponsor was "Aventis Pharmaceuticals" with 2 trials, followed by "Biogen" with 1 trials sponsored, "Case Comprehensive Cancer Center" with 1 trials sponsored, "Dendreon" with 1 trials sponsored and "Facet Biotech" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sidney Kimmel Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Smith Kline Beecham" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sidney Kimmel Cancer Center" are "Leukemia" (3 trials), "Breast Cancer" (1 trials), "Head and Neck Cancer" (1 trials), "Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Sidney Kimmel Cancer Center" in a lesser frequency.

Most popular intervention types in "Sidney Kimmel Cancer Center" are "Drug" (7 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ad5CMV-p53 gene" (1 trials), "Azacitidine 30mg/m2" (1 trials), "Azacitidine 40mg/m2" (1 trials), "Entinostat" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sidney Kimmel Cancer Center" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sidney Kimmel Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sidney Kimmel Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sidney Kimmel Cancer Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".